BI-RADS 3 assessment on MRI: a lesion-based review for breast radiologists
Unlike mammography and US, limited data exist to establish well-defined criteria for MRI
findings that have a≤ 2% likelihood of malignancy. Therefore, determining which findings …
findings that have a≤ 2% likelihood of malignancy. Therefore, determining which findings …
Disparities associated with patient adherence to BI-RADS 3 assessment follow-up recommendations for mammography and ultrasound
Objective To assess the relationship between sociodemographic factors and adherence
rates in patients with a BI-RADS 3 assessment. Methods This retrospective cohort study …
rates in patients with a BI-RADS 3 assessment. Methods This retrospective cohort study …
Outcomes of foci on breast MRI: features associated with malignancy
KS Myers, ET Oluyemi, LA Mullen… - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. The objective of this study was to determine the outcomes of foci seen on
breast MRI and to evaluate imaging features associated with malignancy. MATERIALS AND …
breast MRI and to evaluate imaging features associated with malignancy. MATERIALS AND …
Predicting malignancy in breast lesions: enhancing accuracy with fine-tuned convolutional neural network models
L Li, C Pan, M Zhang, D Shen, G He, M Meng - BMC Medical Imaging, 2024 - Springer
Background This study aims to explore the accuracy of Convolutional Neural Network (CNN)
models in predicting malignancy in Dynamic Contrast-Enhanced Breast Magnetic …
models in predicting malignancy in Dynamic Contrast-Enhanced Breast Magnetic …
Delays in follow-up care for abnormal mammograms in mobile mammography versus fixed-clinic patients
SS Vang, A Dunn, LR Margolies, L Jandorf - Journal of General Internal …, 2022 - Springer
Background Mobile mammographic services (MM) have been shown to increase breast
cancer screening in medically underserved women. However, little is known about MM …
cancer screening in medically underserved women. However, little is known about MM …
Measuring patient‐reported distress from breast magnetic resonance imaging: Development and validation of the MRI‐related distress scale (MRI‐DS)
D Kang, S Kim, J Han, Y Kim, J Cho, JE Lee… - Cancer …, 2024 - Wiley Online Library
Objective Although breast magnetic resonance imaging (MRI) is a valuable screening tool,
breast MRI testing burden was associated with cancer worry and quality of life. We aimed to …
breast MRI testing burden was associated with cancer worry and quality of life. We aimed to …
Outcome of Imaging and Biopsy of BI‐RADS Category 3 Lesions: Follow‐Up Compliance, Biopsy, and Malignancy Rates in a Large Patient Cohort
DS Polat, K Merchant, J Hayes, L Omar… - … of Ultrasound in …, 2023 - Wiley Online Library
Objectives To identify biopsy rates and indications for BI‐RADS 3 lesions in a large cohort of
patients and compare with follow‐up compliance and malignancy outcomes. Methods We …
patients and compare with follow‐up compliance and malignancy outcomes. Methods We …
Patient and System Factors Associated With Completed Follow-Up of Probably Benign (BI-RADS 3) Breast Imaging Findings
CS Giess, E Lynch, R Lacson, N Kapoor… - Journal of the American …, 2023 - Elsevier
Objective Evaluate patient factors and health system test ordering and scheduling processes
associated with completed BI-RADS 3 breast imaging follow-up. Methods Retrospective …
associated with completed BI-RADS 3 breast imaging follow-up. Methods Retrospective …
MRI 影像学特征在生长型BI-RADS 3 类乳腺病变中的应用价值
肖伟, 陈泽莉, 万山, 谢滔 - 分子影像学杂志, 2023 - j-fzyx.com
目的分析MRI 在生长型BI-RADS 3 类乳腺病变中的应用价值. 方法选择2021 年11 月~ 2022
年6 月本院确诊BI-RADS 3 类乳腺病变的115 例患者作为研究对象, 分析其MRI …
年6 月本院确诊BI-RADS 3 类乳腺病变的115 例患者作为研究对象, 分析其MRI …
Breast MRI biopsy cancellation due to lesion nonvisualization
EB Ambinder, KS Myers, LA Mullen… - The Breast …, 2020 - Wiley Online Library
It is a clinical dilemma when a finding reported as suspicious on a breast MRI is not
visualized at the time of a scheduled MRI‐guided breast biopsy. We retrospectively …
visualized at the time of a scheduled MRI‐guided breast biopsy. We retrospectively …